Who Holds Biomarin Pharmaceutical Inc (BMRN)? 564 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 564 holders, $10.9 billion in total.
Largest holders
The 100 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| BlackRock, Inc. | 20,445,212 | $1.2 billion | +3% | 13F |
| Dodge & Cox | 14,844,930 | $849 million | +2% | 13F |
| PRIMECAP MANAGEMENT CO/CA/ | 14,190,183 | $812 million | 0% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 8,743,633 | $500 million | +1% | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8,648,678 | $495 million | +4% | 13F |
| NORGES BANK | 8,207,954 | $470 million | New | 13F |
| STATE STREET CORP | 7,800,959 | $446 million | +7% | 13F |
| VIKING GLOBAL INVESTORS LP | 7,616,563 | $436 million | +8% | 13F |
| Vestal Point Capital, LP | 6,025,000 | $345 million | +69% | 13F |
| AQR CAPITAL MANAGEMENT LLC | 5,699,541 | $323 million | -26% | 13F |
| FMR LLC | 4,822,893 | $276 million | +35% | 13F |
| DIMENSIONAL FUND ADVISORS LP | 4,075,714 | $233 million | +7% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 3,911,794 | $224 million | +2% | 13F |
| Capital Research Global Investors | 3,504,387 | $201 million | +0% | 13F |
| Deep Track Capital, LP | 3,307,481 | $189 million | +188% | 13F |
| MILLENNIUM MANAGEMENT LLC | 2,071,816 | $119 million | -31% | 13F |
| Assenagon Asset Management S.A. | 1,762,086 | $101 million | -8% | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,616,020 | $92 million | +2% | 13F |
| FIRST TRUST ADVISORS LP | 1,606,273 | $92 million | -4% | 13F |
| NORTHERN TRUST CORP | 1,558,104 | $89 million | -2% | 13F |
| MORGAN STANLEY | 1,504,989 | $86 million | +14% | 13F |
| Jones Hill Capital LP | 1,431,590 | $82 million | +13% | 13F |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1,332,836 | $76 million | +57% | 13F |
| Swedbank AB | 1,314,787 | $75 million | +66% | 13F |
| UBS Group AG | 1,286,505 | $74 million | -14% | 13F |
| DNB Asset Management AS | 1,268,194 | $73 million | +4% | 13F |
| Caisse de depot et placement du Quebec | 1,236,446 | $71 million | +31% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 1,223,879 | $70 million | +2% | 13F |
| GOLDMAN SACHS GROUP INC | 1,201,977 | $69 million | +217% | 13F |
| AMERIPRISE FINANCIAL INC | 1,157,865 | $66 million | -1% | 13F |
| Bank of New York Mellon Corp | 1,155,305 | $66 million | +1% | 13F |
| CITADEL ADVISORS LLC | 1,122,408 | $64 million | -75% | 13F |
| Balyasny Asset Management L.P. | 1,054,613 | $60 million | -23% | 13F |
| ARGA Investment Management, LP | 1,039,409 | $59 million | New | 13F |
| FRANKLIN RESOURCES INC | 936,044 | $54 million | +0% | 13F |
| MACKENZIE FINANCIAL CORP | 931,864 | $53 million | +111% | 13F |
| Hudson Bay Capital Management LP | 825,002 | $47 million | -15% | 13F |
| Russell Investments Group, Ltd. | 783,148 | $45 million | +29% | 13F |
| Jupiter Topco LLC | 755,192 | $43 million | New | 13F |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 735,724 | $42 million | -14% | 13F |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 715,646 | $41 million | +0% | 13F |
| LOOMIS SAYLES & CO L P | 713,657 | $41 million | 0% | 13F |
| JPMORGAN CHASE & CO | 694,550 | $41 million | +25% | 13F |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 696,784 | $40 million | +71% | 13F |
| Nuveen, LLC | 689,131 | $39 million | -2% | 13F |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 687,030 | $39 million | +0% | 13F |
| Palo Alto Investors LP | 682,777 | $39 million | 0% | 13F |
| Defilade Capital Management, L.P. | 682,005 | $39 million | New | 13F |
| Qube Research & Technologies Ltd | 668,835 | $38 million | -3% | 13F |
| BANK OF AMERICA CORP /DE/ | 663,163 | $38 million | -29% | 13F |
| Eagle Health Investments LP | 624,676 | $36 million | +24% | 13F |
| VICTORY CAPITAL MANAGEMENT INC | 601,532 | $34 million | +483% | 13F |
| BOONE CAPITAL MANAGEMENT LLC | 583,219 | $33 million | +6% | 13F |
| River Road Asset Management, LLC | 542,990 | $31 million | -41% | 13F |
| Legal & General Group Plc | 537,468 | $31 million | -7% | 13F |
| RHUMBLINE ADVISERS | 516,786 | $30 million | -1% | 13F |
| Trails Edge Capital Partners, LP | 512,000 | $29 million | New | 13F |
| Invesco Ltd. | 494,604 | $28 million | +18% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 490,189 | $28 million | +9% | 13F |
| Jefferies Financial Group Inc. | 466,258 | $27 million | 0% | 13F |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 460,559 | $26 million | -20% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 451,871 | $26 million | -56% | 13F |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 447,200 | $26 million | New | 13F |
| California Public Employees Retirement System | 439,094 | $25 million | -11% | 13F |
| PRINCIPAL FINANCIAL GROUP INC | 438,818 | $25 million | +2% | 13F |
| Rockefeller Capital Management L.P. | 433,376 | $25 million | +16% | 13F |
| SEB Asset Management AB | 412,150 | $24 million | +41% | 13F |
| Robeco Institutional Asset Management B.V. | 408,215 | $23 million | -25% | 13F |
| Pictet Asset Management Holding SA | 395,382 | $23 million | -67% | 13F |
| Allianz Asset Management GmbH | 400,036 | $23 million | +0% | 13F |
| PRUDENTIAL FINANCIAL INC | 392,811 | $22 million | +227% | 13F |
| Soleus Capital Management, L.P. | 375,572 | $21 million | -42% | 13F |
| Man Group plc | 367,981 | $21 million | +19% | 13F |
| Freestone Grove Partners LP | 364,194 | $21 million | -40% | 13F |
| Sofinnova Investments, Inc. | 358,568 | $21 million | -54% | 13F |
| Swiss National Bank | 357,000 | $20 million | -1% | 13F |
| LAZARD ASSET MANAGEMENT LLC | 350,397 | $20 million | +8% | 13F |
| EASTERLY INVESTMENT PARTNERS LLC | 329,387 | $19 million | +33% | 13F |
| SPHERA FUNDS MANAGEMENT LTD. | 328,550 | $19 million | +135% | 13F |
| DIADEMA PARTNERS LP | 312,846 | $18 million | +111% | 13F |
| HSBC HOLDINGS PLC | 307,543 | $18 million | +108% | 13F |
| VAN ECK ASSOCIATES CORP | 307,103 | $18 million | +69% | 13F |
| SECTOR GAMMA AS | 294,918 | $17 million | +23% | 13F |
| Rhenman & Partners Asset Management AB | 290,500 | $17 million | +40% | 13F |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 290,249 | $17 million | +14% | 13F |
| Walleye Capital LLC | 288,233 | $16 million | -21% | 13F |
| ALLIANCEBERNSTEIN L.P. | 283,400 | $16 million | +14% | 13F |
| RAYMOND JAMES FINANCIAL INC | 279,274 | $16 million | -16% | 13F |
| Bridgewater Associates, LP | 274,911 | $16 million | +33% | 13F |
| Susquehanna Portfolio Strategies, LLC | 273,562 | $16 million | +760% | 13F |
| Redmile Group, LLC | 265,169 | $15 million | +53% | 13F |
| Amundi | 259,782 | $15 million | +38% | 13F |
| SEI INVESTMENTS CO | 250,230 | $14 million | 0% | 13F |
| Eversept Partners, LP | 249,607 | $14 million | +20% | 13F |
| Distillate Capital Partners LLC | 248,916 | $14 million | New | 13F |
| RICE HALL JAMES & ASSOCIATES, LLC | 248,224 | $14 million | +137% | 13F |
| Jump Financial, LLC | 245,390 | $14 million | +6816% | 13F |
| CAPITAL FUND MANAGEMENT S.A. | 235,421 | $13 million | +30% | 13F |
| CITIGROUP INC | 228,861 | $13 million | -42% | 13F |
| CANADA PENSION PLAN INVESTMENT BOARD | 224,900 | $13 million | -2% | 13F |
Questions and answers
- How many institutions hold Biomarin Pharmaceutical Inc?
- 564 managers reported Biomarin Pharmaceutical Inc on Form 13F for the quarter ended 30 June 2026, against 559 the quarter before.
- Who is the largest institutional holder of Biomarin Pharmaceutical Inc?
- BlackRock, Inc., with 20,445,212 shares worth $1.2 billion on its 13F for Q2 2026.
- How many institutions bought or sold out of Biomarin Pharmaceutical Inc in Q2 2026?
- 87 managers reported a new position and 82 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Biomarin Pharmaceutical Inc, Q2 2026", https://app.tamarly.ai/holders/biomarin-pharmaceutical, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.